Straumann Holding Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
This Straumann Holding Value Chain Analysis helps you understand how the company creates value across support and primary activities in a clear, structured format. This page already shows a real preview of the analysis, so you can review the actual style and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Straumann Holding AG's firm infrastructure coordinates capital allocation, quality systems, risk controls, and regulatory oversight across a global medtech mix of implants, aligners, scanners, software, and consumables. That matters because each line faces different clinical and compliance rules, so one weak control can hit the full portfolio. In 2025, this central setup also helped Straumann Holding AG absorb acquisitions and keep execution aligned across more than 100 markets.
Straumann Holding AG's 2025 human resource management must keep specialists in R&D, regulatory affairs, manufacturing, clinical education, and direct sales aligned, because its global workforce is about 12,000 employees. Training matters because dental workflows need precision and fast support, so retaining technical and commercial talent helps Straumann Holding AG scale launches without slipping on service quality. In 2025, that people base supports sales of about CHF 2.4 billion and the speed of product rollouts.
In 2025, Straumann Holding AG kept technology development at the center of differentiation, refining implants, biomaterials, intraoral scanners, software, and clear aligner workflows. Digital planning and precision manufacturing improve treatment predictability and help link hardware, software, and clinical protocols. With 2025 sales above CHF 2.5 billion, Straumann Holding AG had scale to keep funding this innovation loop.
Procurement
Straumann Holding AG sources titanium, polymers, electronic components, packaging, and specialized biomaterials from qualified suppliers, so procurement directly affects product quality and clinical consistency. In dental medtech, tight supplier qualification and full traceability reduce defect risk and support regulatory compliance across markets. Efficient buying also helps protect margins and keeps global supply stable for implants, clear aligners, and digital components.
Straumann Holding AG's support activities in 2025 were tightly linked: firm infrastructure kept quality and risk controls aligned across 100+ markets, HR supported about 12,000 employees, technology development sustained CHF 2.5 billion-plus sales, and procurement protected traceability for implants, aligners, and digital tools.
| Support area | 2025 data | Value |
|---|---|---|
| Workforce | About 12,000 | HR scale |
| Sales | CHF 2.5bn+ | R&D support |
| Markets | 100+ | Control reach |
What is included in the product
Primary Activities
Straumann Holding AG's inbound logistics centers on tightly controlled receipt of precision materials, components, and finished inputs with lot-level traceability. That matters because implants, biomaterials, and digital hardware need clean, regulated handling to keep contamination low and production lines running. Careful inbound checks also protect quality across high-value medical workflows where even small defects can trigger costly rework or delays.
Straumann Holding AG's operations turn raw materials into implants, prosthetics, biomaterials, scanners, software-enabled tools, and aligner solutions, with tight validation at each step. In 2025, this scale was reflected in a global platform serving dentists and labs in more than 100 countries. Precision and quality control matter because even small errors can affect fit, function, and clinical outcomes.
Straumann Holding AG moves implants, prosthetics, and consumables through regional supply chains, direct fulfillment, and partner channels in more than 100 countries. Fast, traceable delivery helps clinics and labs avoid treatment delays, so recurring orders keep moving. Efficient outbound logistics also shortens replenishment cycles for high-use consumables and supports service levels across a CHF 2.5 billion-scale business.
Marketing and Sales
Straumann Holding AG relies on clinical education, field teams, digital workflow support, and close professional ties to sell implants, prosthetics, scanners, and aligners. This works because dentists and specialists often want hands-on training and proof before they switch systems. The model also helps Straumann Holding AG build larger account relationships across treatment stages, which supports cross-selling and repeat use.
Service
Straumann Holding AG's service activity covers clinician training, technical support, treatment-planning help, and software updates, which matter because dental workflows are repeated and digitally linked. In 2025, that after-sale support helped lower friction in implant and digital dentistry use, where clinicians need confidence in both the product and the software. Strong service deepens loyalty, supports repeat orders, and makes Straumann Holding AG harder to replace.
Straumann Holding AG's primary activities in 2025 centered on global sales, clinician training, digital workflow support, and after-sales service across more than 100 countries. These steps turn implants, prosthetics, scanners, and aligners into recurring clinical demand. Strong field support helps drive repeat use and cross-selling across treatment stages.
| 2025 metric | Value |
|---|---|
| Countries served | 100+ |
| Business scale | CHF 2.5 billion |
Preview the Actual Deliverable
Straumann Holding Reference Sources
This is the actual Straumann Holding Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so what you see is exactly what you get. Buy now to unlock the complete, detailed version immediately after checkout.
Frequently Asked Questions
Straumann Holding AG's value chain is strongest when its 6 solution groups work as one clinical workflow. The portfolio spans implants, instruments, prosthetics, biomaterials, digital tools, and aligners, while 4 support activities and 5 primary activities keep execution coordinated. That integration is what lets the group sell outcomes, not just individual products.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.